COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic


Summary

Our new report, Germany Tissue Engineered - Skin Substitute Procedures Outlook to 2024, provides key procedures data on the Germany Tissue Engineered - Skin Substitute Procedures. The report provides procedure volumes within market segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.


Scope

  • Germany Tissue Engineered - Skin Substitute Procedures volumes by segments - Biologic Skin Substitute Procedures, Synthetic Skin Substitute Procedures and Biosynthetic Skin Substitute Procedures.
  • Projections for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.




Reasons To Buy

  • Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Develop market-entry and market expansion strategies.